Skip to main content
FOCIS 2023 Main banner
Final Program


Scientific Program

Laurie H. Glimcher, MD

President & CEO
Dana-Farber Cancer Institute
Boston, Massachusetts, United States

Laurie H. Glimcher, MD is the President and CEO of the Dana-Farber Cancer Institute, Director of the Dana-Farber/Harvard Cancer Center and the Richard and Susan Smith Professor of Medicine at Harvard Medical School. Previously, she was the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University. Dr. Glimcher is a widely renowned trailblazer in cancer and immunology research and a member of the National Academy of Sciences and National Academy of Medicine. She served on the Board of Directors of Bristol Myers Squibb Pharmaceuticals and is currently a Director of GlaxoSmithKline Pharmaceuticals and the Waters Corporation.

Dr. Glimcher has been a staunch proponent of improved access to care, health policy, and medical education, while simultaneously serving as a pioneering mentor and role model for cancer research trainees and for all women in science. Notably, she was the first woman to be appointed as dean of Weill Cornell Medicine in New York and is the first female President and CEO of Dana-Farber Cancer Institute.

Disclosure information not submitted.

Presentation(s):